These insights help your provider understand your genetic predisposition to medication response, guiding safer, more personalized dose timingnot accelerating beyond proven protocols
IGF-1 LR3s role in immune regulation highlights its potential as a therapeutic target for managing immune-related and autoimmune disorders (11)
FDA-approved medications for chronic weight management include GLP-1 receptor agonists (semaglutide injection, liraglutide), combination agents (phentermine/topiramate ER, naltrexone/bupropion ER), and lipase inhibitors (orlistat)
Ozempic is sometimes prescribed off-label for weight management by healthcare providers, though this is not its primary FDA-approved indication
Increased risk of heart failure hospitalization with GLP-1 receptor agonists in patients with reduced ejection fraction: a Meta-analysis of the EXSCEL and FIGHT trials
The extent of weight loss may vary among individuals